Based on the genetic evidence that nearly all mutations associated with inherited AD variants are associated with alterations in Aβ production or aggregation, advances in genetic engineering technologies have enabled the development of mouse models using the APP and PSEN1 genes. The gene discussed is APP; the disease is Alzheimer disease.